MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202637036756 A) filed by Nec Oncoimmunity As on March 26, 2026, for T Cell Broad Betacoronavirus Vaccine.
Inventors include Malone, Brandon; Gheorghe, Marius; Clancy, Trevor; Stratford, Richard; and Bendjama, Kaidre.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention relates to polypeptides, polynucleotides, compositions, microorganisms, vectors and vaccine compositions optimised for the treatment or prophylaxis of a disease or infection caused by Betacoronaviruses, including but not limited to: Embecovirus, Hibecovirus, Merbecovirus, Nobecovirus, Sarbecovirus, MERS-CoV, SARS-CoV-1 and SARS-CoV-2. In particular, the invention provides a vaccine composition comprising a polypeptide, wherein the polypeptide comprises one or more epitope sequences, wherein the one or more epitope sequences have the amino acid sequences of any one or more of the sequences of Table 1, or a variant thereof having at least 70% sequence identity thereto, and wherein the polypeptide sequence is no more than 1400 amino acids in length.
Disclaimer: Curated by HT Syndication.
